Abstract
Background: Tribulus terrestris, unlike Tribulus macropterus and Tribulus arabicus, is a well-studied plant species and well known for its medicinal properties. It has been used as a medicine to treat sexual dysfunction and to relieve cardiac pain. It also has other properties such as antihypertensive, anti-microbial, anticancer and antihelmintic. Unfortunately, other Tribulus species such as T. macropterus and T. arabicus (common in the UAE), were not thoroughly investigated for such medicinal properties.
Methods: In this trial, Tribulus terrestris (TT), Tribulus macropterus (TM) and Tribulus arabicus (TA) were tested for their antixodiant properties using DPPH, ABTS, FRAP and β-Carotene assays. Results: TM and TA showed similar or slightly greater antioxidant properties than TT. Similar DPPH scavenging activities (presented as inhibition percent) were observed for both TM (42.7%) and TA (43.8%), and slightly higher than TT (39.9%) at the maximum concentrations (i.e., 1000 ug/ml). For β-Carotene, TT showed absorbance of 0.28 (control) and 0.35 (at 1000 ug/ml). TM and TA had averages of 0.38 and 0.49 vs 0.190 and 0.23 (control and at 1000 ug/ml, respectively) at 470 nm. Conclusion: The results reported here showed similar antioxidant potentials of T. macropterus and T. arabicus when compared to T. terrestris, which place these two Tribulus species at similar levels of antioxidant and medicinal properties as T. terrestris. A subsequent investigation on the potentials of T. macropterus and T. arabicus against sexual dysfunctions in rats is planned. The long-term aim would be to treat sexual dysfunctions in humans using T. macropterus and T. arabicus as an alternative to T. terrestris.Keywords: Plant extracts, sexual dysfunctions, Tribulus, UAE.
Graphical Abstract
Current Bioactive Compounds
Title:Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment
Volume: 13 Issue: 1
Author(s): Taoufik Ksiksi, Abdul Rasheed Palakkott and Shaijal B.T. Ppoyil
Affiliation:
Keywords: Plant extracts, sexual dysfunctions, Tribulus, UAE.
Abstract: Background: Tribulus terrestris, unlike Tribulus macropterus and Tribulus arabicus, is a well-studied plant species and well known for its medicinal properties. It has been used as a medicine to treat sexual dysfunction and to relieve cardiac pain. It also has other properties such as antihypertensive, anti-microbial, anticancer and antihelmintic. Unfortunately, other Tribulus species such as T. macropterus and T. arabicus (common in the UAE), were not thoroughly investigated for such medicinal properties.
Methods: In this trial, Tribulus terrestris (TT), Tribulus macropterus (TM) and Tribulus arabicus (TA) were tested for their antixodiant properties using DPPH, ABTS, FRAP and β-Carotene assays. Results: TM and TA showed similar or slightly greater antioxidant properties than TT. Similar DPPH scavenging activities (presented as inhibition percent) were observed for both TM (42.7%) and TA (43.8%), and slightly higher than TT (39.9%) at the maximum concentrations (i.e., 1000 ug/ml). For β-Carotene, TT showed absorbance of 0.28 (control) and 0.35 (at 1000 ug/ml). TM and TA had averages of 0.38 and 0.49 vs 0.190 and 0.23 (control and at 1000 ug/ml, respectively) at 470 nm. Conclusion: The results reported here showed similar antioxidant potentials of T. macropterus and T. arabicus when compared to T. terrestris, which place these two Tribulus species at similar levels of antioxidant and medicinal properties as T. terrestris. A subsequent investigation on the potentials of T. macropterus and T. arabicus against sexual dysfunctions in rats is planned. The long-term aim would be to treat sexual dysfunctions in humans using T. macropterus and T. arabicus as an alternative to T. terrestris.Export Options
About this article
Cite this article as:
Ksiksi Taoufik, Palakkott Rasheed Abdul and Ppoyil B.T. Shaijal, Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment, Current Bioactive Compounds 2017; 13 (1) . https://dx.doi.org/10.2174/1573407212666161014130546
DOI https://dx.doi.org/10.2174/1573407212666161014130546 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Novel and Emerging Drugs for Leukemias (Guest Editor: Tadeusz Robak)]
Current Cancer Drug Targets Retracted: Effects of Vitamin K2 on Osteoporosis
Current Pharmaceutical Design Meet the Editorial Board
Current Medicinal Chemistry Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review
Current Pharmaceutical Design Production of Retroviral Vectors: Review
Current Gene Therapy Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures
Current Drug Metabolism Genetic Manipulation of Human Embryonic Stem Cells: A System to Study Early Human Development and Potential Therapeutic Applications
Current Gene Therapy Alpha-1 Antitrypsin: It’s Role in Health and Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review
Anti-Cancer Agents in Medicinal Chemistry Self-Assembling Peptides: Potential Role in Tumor Targeting
Current Pharmaceutical Biotechnology Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Current Pharmaceutical Design Current Biomarkers for Lung Cancer
Current Signal Transduction Therapy The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Cancer Electrogene Therapy with Interleukin-12
Current Gene Therapy Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer:Pro- vs Anti-Oxidative Mode of Action-Part II (Guest Editor: Ines Batinic-Haberle)]
Anti-Cancer Agents in Medicinal Chemistry